|
Biotechs on the slow road to recovery but outlook is still unsure (Daily Telegraph)
After the sector’s bubble burst in 2000, things are looking up for the industry, as Nina Montagu-Smith discovered.
(Dec 1, 2007)
CLC bio releases new database solution for researchers (PharmaBiz)
CLC bio, the world's leading bioinformatics solution provider, released CLC Bioinformatics Database to enable research organizations, from small university departments and clinical labs to large biotech and pharmaceutical companies, to maximize their potential, through increased productivity.
(Dec 1, 2007)
Scientists create software to unravel the genetics of inflammation (ANI via Yahoo! India News)
Washington, December 1 (ANI): Researchers at Wake Forest University Baptist Medical Center have developed a powerful tool to aid scientists in studying the genetics of inflammatory diseases, using information about the genes that are known to be linked to inflammation. Dr. Matthew Loza of the Center for Human Genomics at Wake Forest University School of Medicine, has revealed that a web-based ...
(Dec 1, 2007)
Universities vie for money to hire researchers (The Plain Dealer)
Ohio universities submitted 43 proposals to the state, vying for nearly $160 million in grants from the Ohio Research Scholars program largely funded by the Third Frontier Project.
(Dec 1, 2007)
Key gene behind boron toxicity tolerance in barley identified (ANI via Yahoo! India News)
Washington, Dec 2 (ANI): Australian scientists have discovered the key gene behind boron toxicity tolerance in barley, permitting breeders to select barley varieties that are tolerant to boron with 100 percent accuracy. A research team led by Dr Tim Sutton of the Australian Centre for Plant Functional Genomics at the University of Adelaide's School of Agriculture, Food and Wine at the Waite ...
(Dec 2, 2007)
Newly-identified exercise gene could help with depression (EurekAlert!)
New Haven, Conn.—Boosting an exercise-related gene in the brain works as a powerful anti-depressant in mice—a finding that could lead to a new anti-depressant drug target, according to a Yale School of Medicine report in Nature Medicine.
(Dec 2, 2007)
New genetic findings on malaria parasite (News-Medical-Net)
The malaria parasite has been studied for decades, but surprisingly, little is known about how it behaves in humans to cause disease.
(Dec 2, 2007)
Newly-identified Exercise Gene Could Help With Depression (Science Daily)
Boosting an exercise related gene in the brain functions as a powerful anti-depressant, at least in mice. The researchers said it is known that exercise improves brain function and mental health, and provides protective benefits in the event of a brain injury or disease, but how this all happens in the brain is not well understood. He said the fact that existing medications take so long to work ...
(Dec 2, 2007)
NASA Spaceline 16 November 2007 Current Space Life Science Awareness (SpaceRef)
The abstract in PubMed or at the publisher's site is linked when available and will open in a new window.
(Dec 3, 2007)
MEXIDATA . INFO (MEXIDATA . INFO)
On November 20 th , 2007, Dr. Jose Narro Robles was inaugurated as the new president of Mexico’s Universidad Nacional Autónoma de México , the National Autonomous University of Mexico, known by the acronym UNAM.
(Dec 3, 2007)
New Labs Study How Insects Adapt to Climate Change (University of Melbourne University News)
Innovation Minister Gavin Jennings today opened cutting-edge laboratories for the Centre for Environmental Stress and Adaptation Research (CESAR) in Victoria.
(Dec 3, 2007)
Incubator to join UNCC research HQ (BizJournals)
UNC Charlotte wants to build a $30 million research facility that would house its business incubator, the Ben Craig Center.
(Dec 3, 2007)
Ludesi Announces New Image & Data Management Software for Its 2D Gel Image Analysis Service at SPS 2007 (Marketwire via Yahoo! Finance)
SPS 2007 -- Ludesi AB, developer and provider of the industry-leading Ludesi Image Analysis Service for 2-dimensional electrophoresis gels, today announced the immediate availability of a major new software application to complement its analysis service. The new Ludesi REDFIN Image and Data Management software features a powerful and intuitive user interface that allows researchers and ...
(Dec 3, 2007)
03.12.2007 - DJ HUGIN NEWS/QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products (4investors)
VENLO, The Netherlands / SINGAPORE, December 3, 2007 - QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of sample and assay technologies, and Bio*One Capital, one of the largest dedicated biomedical investment management companies in Asia, today announced that they have entered into a joint venture to establish Dx Assays Pte Ltd ("Dx Assays").
(Dec 3, 2007)
Learn about the Licensing Strategies - Examining Today's Pharmaceutical Licensing Trends (Business Wire via Yahoo! Finance)
NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
(Dec 3, 2007)
Exercise-related gene may harbour depression cure (ANI via Yahoo! India News)
London, Dec 3 (ANI): Scientists at Yale School of Medicine has discovered that an exercise-related gene in the brain may harbour the cure for depression. The research led by Ronald Duman, professor of psychiatry, found that the gene works as a powerful anti-depressant in mice, and state that this could lead to a new anti-depressant drug target. "The VGF exercise-related gene and target for ...
(Dec 3, 2007)
Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and ... (Business Wire via Yahoo! Finance)
BILLERICA, Mass.----Bruker BioSciences Corporation announced today that it has entered into definitive agreements to acquire the companies of the privately held Bruker BioSpin group for $388 million in cash and for 57.5 million in Bruker BioSciences shares, valued at $526 million at the November 28, 2007 trailing 10 trading day average closing price of $9.14 per BRKR share.
(Dec 3, 2007)
Buck Institute and Neurobiological Technologies, Inc. Partner to Develop Treatment for Huntington's Disease (PR Newswire via Yahoo! Finance)
Neurobiological Technologies, Inc. and the Buck Institute for Age Research today announced they have formed a partnership to develop a drug to treat Huntington's disease , a fatal hereditary brain disorder that affects approximately 30,000 Americans.
(Dec 3, 2007)
Ceres Funds Switchgrass Development in South Dakota (PR Newswire via Yahoo! Finance)
Energy crop company Ceres, Inc. announced today that it is sponsoring research at South Dakota State University in Brookings to develop improved switchgrass for the northern Great Plains.
(Dec 3, 2007)
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass. & CARLSBAD, Calif.----Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. formed to discover, develop and commercialize microRNA therapeutics, announced today the appointment of Kleanthis G.
(Dec 3, 2007)
Researchers Develop Powerful Tool To Study The Genetics Of Inflammation (Medical News Today)
Scientists have known which genes are linked to inflammation, but now researchers at Wake Forest University Baptist Medical Center have organized this information to develop a powerful tool to aid investigators in studying the genetics of inflammatory diseases. [click link for full article]
(Dec 3, 2007)
Creation of the Swiss Institute for Vaccine Research in Lausanne, Switzerland (Business Wire via Yahoo! Finance)
LAUSANNE, Switzerland----Under embargo for publication until 5 December 17h00 CET
(Dec 3, 2007)
Creation of the Swiss Institute for Vaccine Research (Newswise)
Lausanne, Switzerland, 3 December 2007-- The Swiss Institute for Vaccine Research will be launched on December 5, 2007, in Lausanne, Switzerland. The new Institute will encompass the principal aspects of vaccine research to fight the three main infectious diseases : HIV/AIDS, tuberculosis and malaria. The Institute will also benefit from ongoing vaccine research in cancer and influenza.
(Dec 3, 2007)
Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based ... (PR Newswire via Yahoo! Finance)
Rosetta Genomics announced today that in preparation for the launch of its first microRNA-based diagnostic products in 2008, it is strengthening its management team. Ronen Tamir has been appointed to the newly created position of Executive Vice President, Marketing and Communication, and will lead the commercialization of the company's first-ever microRNA-based diagnostic products.
(Dec 3, 2007)
Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based ... (FinanzNachrichten)
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, December 3 /PRNewswire-FirstCall/ -- Rosetta Genomics ( Nachrichten ) announced today that in preparation for the launch of its first microRNA-based diagnostic products in 2008, it is strengthening its management team.
(Dec 3, 2007)
Move over Bill Nye - there's a new science guy (Cavalier Daily Online)
Everyone knows the University draws some of the best and brightest students from across the country, and many alumni go on to achieve great things. One need only watch Tina Fey on "30 Rock" or recall Tiki Barber's impressive NFL career to appreciate the success of University graduates.
(Dec 3, 2007)
Ludesi Announces New Image & Data Management Software for Its 2D Gel Image Analysis Service (Marketwire via Yahoo! Finance)
Ludesi AB, developer and provider of the industry-leading Ludesi Image Analysis Service for 2-dimensional electrophoresis gels, today announced the immediate availability of a major new software application to complement its analysis service. The new Ludesi REDFIN Image and Data Management software features a powerful and intuitive user interface that allows researchers and scientists to ...
(Dec 3, 2007)
Genetix Introduces Two New ''CloneMedia'' Semi-Solid Media Reagents (Business Wire via Yahoo! Finance)
NEW MILTON, UK & WASHINGTON, D.C.----Genetix, a leading developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, announces the expansion of its "CloneMedia" range of semi-solid media products for mammalian cell cloning.
(Dec 3, 2007)
Thousand Oaks, California and Brookings, South Dakota December 3, 2007 (SeedQuest)
Energy crop company Ceres, Inc. announced today that it is sponsoring research at South Dakota State University in Brookings to develop improved switchgrass for the northern Great Plains.
(Dec 3, 2007)
Exercise may boost brain's natural antidepressant (Reuters via Yahoo! News)
Exercise seems to increase the production of naturally occurring brain chemical with antidepressant effects in mice, researchers reported Sunday.
(Dec 3, 2007)
Story ideas from the Journal of Lipid Research (EurekAlert!)
Researchers have found that variants in two metabolic genes alter how the body adjusts cholesterol metabolism in response to weight loss, a finding that may lead to screening tools to identify the optimal method of reducing cholesterol levels in specific individuals.
(Dec 3, 2007)
Newly Identified Exercise Gene Could Help with Depression (Yale University)
Boosting an exercise-related gene in the brain works as a powerful anti-depressant in mice—a finding that could lead to a new anti-depressant drug target, according to a Yale School of Medicine report in Nature Medicine.
(Dec 3, 2007)
Exercise may boost brain's natural antidepressant (Environmental News Network)
NEW YORK (Reuters Health) - Exercise seems to increase the production of naturally occurring brain chemical with antidepressant effects in mice, researchers reported Sunday. The findings, published in the journal Nature Medicine, point to potential new ways to treat depression in people. Studies have found that exercise can help ease depression symptoms, but the reasons for the benefit ...
(Dec 3, 2007)
Story Ideas from the Journal of Biological Chemistry (Newswise)
1) Genetic Variants Affect Diet-Associated Cholesterol Metabolism; 2) Crohn's Disease Increases Progression of Atherosclerosis; 3) Breaking the Vicious Cycle of Bile Acid Disorders.
(Dec 3, 2007)
Adelaide, South Autralia November 30, 2007 (SeedQuest)
Adelaide scientists have identified the major gene responsible for boron toxicity tolerance in barley, allowing breeders to select with 100% accuracy barley varieties that are tolerant to boron. The findings have today been published in the journal, Science.
(Dec 3, 2007)
Boosting an exercise-related gene in the brain works as a powerful anti-depressant in mice (News-Medical-Net)
This finding could lead to a new anti-depressant drug target, according to a Yale School of Medicine report in Nature Medicine.
(Dec 3, 2007)
New tool for analyzing genetic variations in the inflammation pathways (News-Medical-Net)
Scientists have known which genes are linked to inflammation, but now researchers at Wake Forest University Baptist Medical Center have organized this information to develop a powerful tool to aid investigators in studying the genetics of inflammatory diseases.
(Dec 3, 2007)
State sees slowdown in bioscience grants (East Valley Tribune)
Halfway through a 10-year plan to establish itself as a bioscience center, Arizona has experienced a slowdown in federally funded research grants.
(Dec 3, 2007)
Luminex Corporation Launches FlexmiR Select (FinanzNachrichten)
Luminex Corporation ( Nachrichten ) (NASDAQ: LMNX), the world leader in multiplexed solutions, today launched FlexmiR Select, a new microRNA (miRNA) assay designed to allow researchers to further advance understanding and enhance the analysis of miRNAs.
(Dec 3, 2007)
MWG and Operon Are Joining Forces (PR Newswire via Yahoo! Finance)
Operon Biotechnologies, Eurofins MWG and Eurofins Medigenomix - all part of the Eurofins Genomics network - announced today that they have agreed to work together in order to create a new worldwide leader in the competitive custom oligonucleotide market.
(Dec 3, 2007)
Study finds genetic testing may help people with severe type of migraine (EurekAlert!)
ST. PAUL, Minn. - People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem.
(Dec 3, 2007)
Feinstein researchers develop new genetic method and identify novel genes for schizophrenia (EurekAlert!)
GLEN OAKS, NY – Scientists at the Zucker Hillside Hospital campus of the Feinstein Institute for Medical Research have identified nine genetic markers that can increase a person’s risk for schizophrenia.
(Dec 3, 2007)
HBIO Divests the Majority of its Capital Equipment Business (Finanzen.net)
Harvard Bioscience, Inc. (NASDAQ: HBIO) today announced it has completed the sale of its Genomic Solutions Division and its Belgian subsidiary, Maia Scientific, both part of its Capital Equipment Business Segment, to Digilab, Inc. ...
(Dec 3, 2007)
Roadmap update: Biotech on growth track, but funding a challenge (BizJournals)
Arizona's biotech industry has steadily grown, but still faces financial challenges.
(Dec 3, 2007)
Genetic Testing May Help People With Severe Type Of Migraine (Science Daily)
People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem. Screening for familial genes in people with this type of sporadic migraine may also help to enable counseling and prevent unnecessary ...
(Dec 4, 2007)
Malaria Parasite In Patient Blood Finds Distinct Physiological States (Science Daily)
For the first time, scientists have measured which of the malaria parasite's genes are turned on or off during actual infection in humans, not in cell cultures, unearthing surprising behaviors and opening a window on the most critical aspects of parasite biology.
(Dec 4, 2007)
CU high-tech may save lives (Colorado Daily)
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
(Dec 4, 2007)
KU lecturer one of few who mapped human genome (Lawrence Journal-World)
There are few people — perhaps only one — who have their complete genetic makeup available for public scrutiny. That one person, Craig Venter, founder of Celera Genomics, set out to map the human genome in 1998 and succeeded in 2001, about the same time as a national team of scientists, said Valentino Stella, a distinguished professor of pharmaceutical chemistry at Kansas University.
(Dec 4, 2007)
Extensive Proteomics Research Strengthens the Uptake for Protein Purification Kits in Europe (Business Wire via Yahoo! Finance)
LONDON----The growing need for the production of more proteins within faster timelines is forcing laboratories to look for better expression systems and automated solutions to meet their demands.
(Dec 4, 2007)
Genetic Testing May Help People With Severe Type Of Migraine (Medical News Today)
People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem. The findings are published in the December 4, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology. [click ...
(Dec 4, 2007)
|
